Related Experiment Video

Updated: Jun 13, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Early-life respiratory syncytial virus disease and long-term respiratory health

Heather J Zar1, Ferdinand Cacho2, Tahira Kootbodien1

  • 1Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.

The Lancet. Respiratory Medicine
|September 12, 2024
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe lung infections in children, leading to long-term respiratory issues. New preventive measures show promise but require wider access, especially in low-income countries.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Respiratory syncytial virus (RSV) is a major global cause of severe lower respiratory tract infections (LRTI) in children.
  • Early-life RSV LRTI is linked to persistent respiratory problems, including asthma and impaired lung function into adulthood.
  • Existing preventive strategies like maternal vaccines and monoclonal antibodies offer passive immunization but face access challenges in low- and middle-income countries (LMICs).

Purpose of the Study:

  • To review evidence on the long-term respiratory consequences of early-life RSV disease.
  • To explore the mechanisms underlying the development of these long-term effects.
  • To evaluate the potential public health impact of RSV prevention interventions.

Main Methods:

  • Systematic review of existing literature on RSV and long-term respiratory health.
  • Analysis of data on the efficacy and effectiveness of current RSV prevention strategies.
  • Discussion of disease development pathways and public health implications.

Main Results:

  • RSV infection in early life is a significant risk factor for chronic respiratory conditions.
  • Preventive measures are highly effective in reducing severe RSV LRTI, particularly in high-income nations.
  • Limited access to these interventions in LMICs hinders their full public health potential.

Conclusions:

  • Preventing or delaying early-life RSV infection may mitigate long-term respiratory morbidity.
  • Equitable access to RSV prevention in LMICs is crucial for reducing the global burden of childhood respiratory disease.
  • Further research is needed to confirm the long-term benefits of RSV prevention on subsequent respiratory health outcomes.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.8K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.4K

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
339
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
807
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124